iib osteosarcoma current manag local control surviv statist sao paulo brazil ninety-two patient iib osteosarcoma extrem intraarteri IA cisplatinum cddp surgeri amput resect endoprosthesi postop chemotherapi adriamycin cddp total three-year surviv disease-fre surviv patholog evalu degre tumor necrosi respons IA cddp necrosi multivari analysi prognost factor surviv femal tumor cm patient lesion equal cm time like diseas second aggress studi high dose methotrex hdmtx adriamycin cddp oper ifosfamid case degre tumor necrosi group patient hdmtx addit cddp adriamycin last drug arm complet remiss follow-up examin month averag month extrem import major author patient tumor initi evalu cm diamet 